Matches in Wikidata for { <http://www.wikidata.org/entity/Q92984022> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q92984022 description "article scientifique publié en 2020" @default.
- Q92984022 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q92984022 description "im Januar 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92984022 description "scientific article published on 28 January 2020" @default.
- Q92984022 description "wetenschappelijk artikel" @default.
- Q92984022 description "наукова стаття, опублікована 28 січня 2020" @default.
- Q92984022 name "Cryoablation-activated enhanced nanodoxorubicin release for the therapy of chemoresistant mammary cancer stem-like cells" @default.
- Q92984022 name "Cryoablation-activated enhanced nanodoxorubicin release for the therapy of chemoresistant mammary cancer stem-like cells" @default.
- Q92984022 type Item @default.
- Q92984022 label "Cryoablation-activated enhanced nanodoxorubicin release for the therapy of chemoresistant mammary cancer stem-like cells" @default.
- Q92984022 label "Cryoablation-activated enhanced nanodoxorubicin release for the therapy of chemoresistant mammary cancer stem-like cells" @default.
- Q92984022 prefLabel "Cryoablation-activated enhanced nanodoxorubicin release for the therapy of chemoresistant mammary cancer stem-like cells" @default.
- Q92984022 prefLabel "Cryoablation-activated enhanced nanodoxorubicin release for the therapy of chemoresistant mammary cancer stem-like cells" @default.
- Q92984022 P1104 Q92984022-E1F3A3C4-6040-4AF6-A2DF-2EB87A4CAC0C @default.
- Q92984022 P1433 Q92984022-B3804C7E-0996-4FCA-8195-A2CF60BA9B08 @default.
- Q92984022 P1476 Q92984022-D0757643-B5CD-4FD7-A1D2-22FB62B4B27E @default.
- Q92984022 P2093 Q92984022-660B7EF0-7B50-4929-AE9F-5BF395DADDB5 @default.
- Q92984022 P2093 Q92984022-8EE14267-AD5B-4C3A-B8A5-945E65657CDC @default.
- Q92984022 P2093 Q92984022-A7F3AFCF-38A0-4E0B-AC0D-8B915B419922 @default.
- Q92984022 P2093 Q92984022-EEAABCDB-AF79-454B-BE10-1B2020B97BEF @default.
- Q92984022 P304 Q92984022-85B97643-5A20-4D4F-9569-93E388006FD6 @default.
- Q92984022 P31 Q92984022-7BBBBA7C-2BBE-4AFF-9ABF-3DD4E148B55A @default.
- Q92984022 P356 Q92984022-7C1C640D-346E-412D-A536-36FB6926BAF4 @default.
- Q92984022 P433 Q92984022-CC8C0630-870F-452D-BAE7-B31F743CF15E @default.
- Q92984022 P478 Q92984022-E8B95A4A-B11D-43A8-B33E-0B9349C9F058 @default.
- Q92984022 P50 Q92984022-BE966011-9F9D-45BA-8F94-47F6E260AC6D @default.
- Q92984022 P577 Q92984022-2647F3E3-8EEB-4414-B732-7A70402F53B1 @default.
- Q92984022 P698 Q92984022-AA5DD112-D61A-418E-A481-12711832A6AC @default.
- Q92984022 P356 C9TB01922G @default.
- Q92984022 P698 31989140 @default.
- Q92984022 P1104 "+11" @default.
- Q92984022 P1433 Q18712374 @default.
- Q92984022 P1476 "Cryoablation-activated enhanced nanodoxorubicin release for the therapy of chemoresistant mammary cancer stem-like cells" @default.
- Q92984022 P2093 "Siyuan Yao" @default.
- Q92984022 P2093 "Xiaoming He" @default.
- Q92984022 P2093 "Xuyang Sun" @default.
- Q92984022 P2093 "Yi Hou" @default.
- Q92984022 P304 "908-918" @default.
- Q92984022 P31 Q13442814 @default.
- Q92984022 P356 "10.1039/C9TB01922G" @default.
- Q92984022 P433 "5" @default.
- Q92984022 P478 "8" @default.
- Q92984022 P50 Q58802874 @default.
- Q92984022 P577 "2020-01-28T00:00:00Z" @default.
- Q92984022 P698 "31989140" @default.